Search bioRxiv⌕ Search

Biology subjects

Cirotti, C.

Publications and source records attributed to Cirotti, C..

2 recordsLinked to original sources

Caspase-8 is a novel modulator of Homologous Recombination Repair in response to ionizing radiations

Caspase-8 is a cysteine protease historically regarded as anti-neoplastic protein, thanks to its role in apoptosis. However, Caspase-8 expression is retained or even enhanced in several tumors, including glioblastoma (GBM), where it plays pro-tumor functions. We previously reported that it is a negative prognostic factor and contributes to resistance against DNA damaging agents, such as ionizing radiations (IR) and Temozolomide, commonly used in standard GBM treatment. We therefore investigated whether Caspase-8 may sustain DNA repair pathways proficiency in GBM. Here we uncover a novel role of Caspase-8 as promoter of the Homologous Recombination Repair (HRR). Importantly, IR promote Caspase-8 transient nuclear translocation and its recruitment to the chromatin. Moreover, Caspase-8 sustains the expression and the recruitment to the chromatin upon IR of RAD51 and CtIP, two key players of the HRR. Consistently, we identify a synthetically lethal interaction between Caspase-8 and PARP inhibition, that may ameliorate GBM response to IR. Remarkably, by using Caspase-8-/- murine embryo fibroblasts and a Drosophila melanogaster Caspase-8 mutant, we demonstrate that Caspase-8 plays an evolutionary conserved role in DNA repair. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=149 HEIGHT=200 SRC="FIGDIR/small/656091v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@1016001org.highwire.dtl.DTLVardef@145ed73org.highwire.dtl.DTLVardef@1e847d5org.highwire.dtl.DTLVardef@c417e1_HPS_FORMAT_FIGEXP M_FIG C_FIG

cancer biology↗

NRF2 connects Src tyrosine kinase to ferroptosis resistance in glioblastoma

Glioblastoma (GBM) is a severe brain tumor characterized by an extremely poor survival rate of patients. GBM cancer cells escape to standard therapeutic protocols consisting of combination of ionizing radiation (IR) and alkylating drugs that trigger DNA damage, by rewiring of signaling pathways. In recent years, the upregulation of factors that counteract ferroptosis has been highlighted as a major driver of cancer resistance to IR, although the molecular connection between the activation of oncogenic signaling and the modulation of ferroptosis has not been clarified yet. Here we provide the first evidence for a molecular connection between the constitutive activation of tyrosine kinases and resistance to ferroptosis. Src tyrosine kinase, a central hub on which Receptor Tyrosine Kinases deregulated signaling converge in cancer, leads to the stabilization and activation of NRF2 pathway, thus promoting resistance to IR-induced ferroptosis. These data suggest that the upregulation of Src-NRF2 axis may represent a vulnerability for combined strategies that, by targeting ferroptosis resistance, enhance radiation sensitivity in glioblastoma.

cancer biology↗